Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies

Alzheimer's and Dementia

Volumn 4, Issue 4, 2008, Pages 280-284

  Zhu, Carolyn W ^a,b   Scarmeas, Nikolaos ^c,d   Stavitsky, Karina ^c,d   Albert, Marilyn ^e   Brandt, Jason ^e   Blacker, Deborah ^f   Sano, Mary ^a,b   Stern, Yaakov ^c,d  

^a Education   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Cost of care; Dementia; Dementia with Lewy bodies; Economics

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BLESSED DEMENTIA RATING SCALE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; COST OF ILLNESS; COST UTILITY ANALYSIS; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DRUG COST; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RATING SCALE; SYMPTOM; UNITED STATES;

AGED; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; LEWY BODY DISEASE; MALE;

EID: 45849102102     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2008.02.008     Document Type: Article

References (21)

1. McKeith I., Mintzer J., Aarsland D., Burn D., Chiu H., Cohen-Mansfield J., et al. Dementia with Lewy bodies. Lancet Neurol 3 (2004) 19-28
2. Murman D.L., Kuo S.B., Powell M.C., and Colenda C.C. The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies. Neurology 61 (2003) 944-949
3. Bostrom F., Jonsson L., Minthon L., and Londos E. Patients with Lewy body dementia use more resources than those with Alzheimer's disease. Int J Geriatr Psychiatry 22 (2007) 713-719
4. Stern Y., Folstein M., Albert M., Richards M., Miller L., Bylsma F., et al. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"): I0151study design, cohort description, and intersite comparisons. Alzheimer Dis Assoc Disord 7 (1993) 3-21
5. Richards M., Folstein M., Albert M., Miller L., Bylsma F., Lafleche G., et al. Multicenter study of predictors of disease course in Alzheimer disease (the "predictors study"): II-neurological, psychiatric, and demographic influences on baseline measures of disease severity. Alzheimer Dis Assoc Disord 7 (1993) 22-32
6. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
7. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
8. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
9. Stern Y., M S., Paulson J., and Mayeux R. Modified mini-mental state examination: validity and reliability. Neurology 37 Suppl 1 (1987) 179
10. Zhu C.W., Scarmeas N., Torgan R., Albert M., Brandt J., Blacker D., et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology 67 (2006) 998-1005
11. Zhu C.W., Scarmeas N., Torgan R., Albert M., Brandt J., Blacker D., et al. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology 66 (2006) 1021-1028
12. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114 (1968) 797-811
13. Devanand D.P., Miller L., Richards M., Marder K., Bell K., Mayeux R., et al. The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol 49 (1992) 371-376
14. Stern Y., Tang M.X., Albert M.S., Brandt J., Jacobs D.M., Bell K., et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 277 (1997) 806-812
15. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
16. Scarmeas N., Brandt J., Albert M., Hadjigeorgiou G., Papadimitriou A., Dubois B., et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 62 (2005) 1601-1608
17. Council of Economic Advisers. Economic report of the President (2003) Washington, DC
18. Neyman J.S. On the application of probability theory to agriculture experiments: essay on principles-section 9. Statistical Science 5 (1990) 465-485
19. Abadie A., Drukker D., Herr J., and Imbens G. Implementing matching estimators for average treatment effects in Stata. The Stata Journal 4 (2004) 290-311
20. Husaini B.A., Sherkat D.E., Levine R., Bragg R., Holzer C., Anderson K., et al. Race, gender, and health care service utilization and costs among Medicare elderly with psychiatric diagnoses. J Aging Health 14 (2002) 79-95
21. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572